Triple-negative breast cancer (TNBC) is a breast cancer subtype that lacks estrogen receptor (ER) and progesterone receptor (PR) expression and does not exhibit human epidermal growth factor receptor 2 (HER2) amplification. This evidence concerns the gene ERBB2 and breast cancer.